Breaking News
LAST CHANCE for Cyber Monday SALE: Up to 54% off InvestingPro! Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

iCo Therapeutics Inc (MSCL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.4700 +0.1700    +13.08%
26/11 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 215,380
  • Bid/Ask: 1.4500 / 1.4800
  • Day's Range: 1.2400 - 1.5500
Type:  Equity
Market:  Canada
ISIN:  CA80401L3083 
S/N:  80401L308
iCo Therapeutics Inc 1.4700 +0.1700 +13.08%
IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program focuses on the development of a therapeutic for correcting the impaired muscle regenerative process in genetic pediatric disease, duchenne muscular dystrophy (DMD), a genetic disease that involves the mutation and functional disruption of the DMD gene and loss of Dystrophin. The company was incorporated in 2012 and is headquartered in Toronto, Canada.

Contact Information

Top Executives

Name Age Since Title
John R. Perfect - 2018 Member of Clinical Advisory Board
David W. Denning - 2018 Member of Clinical Advisory Board
Coleman Rotstein - 2010 Member of Scientific Advisory Board
Jack D. Sobel - 2010 Member of Scientific Advisory Board
Philip J. Rosenfeld - 2006 Member of Clinical Advisory Board
Thomas J. Walsh - 2010 Member of Scientific Advisory Board
David S. Boyer - 2006 Member of the Clinical Advisory Board
Andrea Leonardi - - Member of the Clinical Advisory Board
Michael Liggett 61 2016 CFO, Corporate Secretary & Director
Julia G. Levy 86 2005 Member of the Strategic Advisory Board
Richard M. Glickman 63 2005 Member of the Strategic Advisory Board
Alan Bird - 2006 Member of the Clinical Advisory Board
Donald N. Buell - - Chairman of the Scientific Advisory Board
Jason Scott Slakter 63 - Member of Clinical Advisory Board
William Wasyl Jarosz 65 2006 Chairman of the Board & CEO
Peter Hnik 65 2006 Chief Medical Officer & Director
Geoff MacKay 55 - Chairman of the Board of Directors
Francis Gleeson 66 2012 Co-Founder, CEO, President & Director
William K. McVicar 63 - Independent Director
William Wasyl Jarosz 65 2021 Executive Director
Brian Matthew Bloom 44 2018 Director
John Holyoake 40 2018 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MSCL Comments

Write your thoughts about iCo Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email